<div id="readability-page-1"><p>Simulations Plus (NASDAQ:SLP - Get Free Report) updated its FY 2026 earnings guidance on Thursday. The company provided EPS guidance of 1.030-1.100 for the period, compared to the consensus EPS estimate of 1.010. The company issued revenue guidance of $79.0 million-$82.0 million, compared to the consensus revenue estimate of $79.6 million.</p><div><p><span></span><span>Get <strong>Simulations Plus</strong> alerts:</span></p></div><h2>Analyst Ratings Changes</h2><ul><li>52-Week Lows? No Problem for 3 Stocks With Big Upside Potential</li></ul><p>A number of analysts have weighed in on SLP shares. Citigroup  reissued a &#34;market perform&#34; rating on shares of Simulations Plus in a report on Tuesday, October 28th. TD Cowen initiated coverage on shares of Simulations Plus in a research report on Tuesday, September 30th. They issued a &#34;hold&#34; rating and a $16.00 target price on the stock. KeyCorp  reissued a &#34;sector weight&#34; rating on shares of Simulations Plus in a research report on Wednesday, October 29th. Weiss Ratings  restated a &#34;sell (d-)&#34; rating on shares of Simulations Plus in a research note on Wednesday, October 8th. Finally, Cowen began coverage on Simulations Plus in a research report on Tuesday, September 30th. They set a &#34;hold&#34; rating on the stock. One investment analyst  has rated the stock with a Strong Buy rating, four have given a Buy rating, five have assigned  a Hold rating and one  has assigned  a Sell rating to the company's stock. Based on data from MarketBeat, the stock  has an average rating of &#34;Hold&#34; and an average target price of $24.40.</p><p><b>View Our Latest Stock Analysis on SLP</b></p><h2>Simulations Plus Price Performance</h2><ul><li>Simulations Plus Stock Drops 15% Despite EPS Beat</li></ul><p>Shares of NASDAQ SLP opened at $19.80 on Thursday. The stock has a fifty day moving average price of $17.21 and a 200 day moving average price of $17.14. Simulations Plus has a 1-year low of $12.39 and a 1-year high of $37.67. The company has a market cap of $398.97 million, a PE ratio of -6.15 and a beta of 1.16. </p><p>Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings data on Monday, December 1st. The technology company reported $0.10 EPS for the quarter, hitting analysts' consensus estimates of $0.10. Simulations Plus had a negative net margin of 81.74% and a positive return on equity of 13.27%. The company had revenue of $17.46 million during the quarter, compared to the consensus estimate of $17.41 million. During the same quarter in the prior year, the firm earned $0.06 EPS.  Analysts anticipate that  Simulations Plus will post 1.09 earnings per share for the current fiscal year. </p><h2>Hedge Funds Weigh In On Simulations Plus</h2><ul><li>Simulations Plus: A Health Care Stock with Healthy Growth Prospects</li></ul><p>Several hedge funds and other institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of  Simulations Plus by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company's stock valued at $233,000 after purchasing an additional 390 shares during the period.  Prudential Financial Inc. boosted its holdings in shares of  Simulations Plus by 5.7% during the 2nd quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company's stock worth $300,000 after buying an additional 930 shares in the last quarter.  Invesco Ltd. boosted its holdings in shares of  Simulations Plus by 3.8% during the 2nd quarter. Invesco Ltd. now owns 36,452 shares of the technology company's stock worth $636,000 after buying an additional 1,323 shares in the last quarter.  Raymond James Financial Inc. acquired a new stake in shares of  Simulations Plus during the 2nd quarter worth approximately $25,000.  Finally, US Bancorp DE increased its stake in shares of  Simulations Plus by 32.5% in the 3rd quarter. US Bancorp DE now owns 6,167 shares of the technology company's stock valued at $93,000 after acquiring an additional 1,513 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds. </p><h2>About Simulations Plus</h2> (Get Free Report)<p>Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Simulations Plus</li><li>What is the NASDAQ Stock Exchange?</li><li>Market Momentum: 3 Stocks Poised for Major Breakouts</li><li>What is the Hang Seng index?  </li><li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li><li>Stock Market Upgrades: What Are They?</li><li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0xQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U0xQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Simulations Plus Right Now?</h2><p>Before you consider Simulations Plus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.</p><p>While Simulations Plus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Simulations Plus (NASDAQ:SLP) updated its FY 2026 earnings guidance, projecting EPS of 1.030-1.100, above the consensus estimate of 1.010. Revenue guidance is set at $79.0 million-$82.0 million, compared to the consensus of $79.6 million. Analysts have mixed ratings on SLP, with an average rating of "Hold" and a target price of $24.40. The stock opened at $19.80, with a market cap of $398.97 million. Institutional investors hold 78.08% of the stock.</p>

Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance